Silence Therapeutics (SLNCF, $1.47) was a top loser over the last three months, falling -7 to $1.47 per share. A.I.dvisor analyzed 850 stocks in the Biotechnology Industry for the 3-month period ending February 13, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.